Extending our knowledge of fermentable, short-chain carbohydrates for managing gastrointestinal symptoms

Nutrition in Clinical Practice

Volumn 28, Issue 3, 2013, Pages 300-306

  Barrett, Jacqueline S ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

abdominal pain; carbohydrates; diarrhea; diet therapy; FODMAP; gastrointestinal diseases; irritable bowel syndrome

Indexed keywords

DISACCHARIDE; MONOSACCHARIDE; OLIGOSACCHARIDE; POLYOL;

ABDOMINAL PAIN; AUSTRALIA; BLOATING; CLINICAL FEATURE; CONSTIPATION; CONTROLLED CLINICAL TRIAL (TOPIC); DEFECATION HABIT; DIARRHEA; DIET; FIBER; FLATULENCE; HUMAN; INTESTINE FLORA; IRRITABLE COLON; MALABSORPTION; RETROSPECTIVE STUDY; REVIEW; STOMACH ABSORPTION;

ABDOMINAL PAIN; CARBOHYDRATES; DIARRHEA; DIET THERAPY; FODMAP; GASTROINTESTINAL DISEASES; IRRITABLE BOWEL SYNDROME;

ABDOMINAL PAIN; AUSTRALIA; DIARRHEA; DIET; DIET, CARBOHYDRATE-RESTRICTED; DIETARY FIBER; DISACCHARIDES; FERMENTATION; FOOD HABITS; GASTROINTESTINAL TRACT; HUMANS; IRRITABLE BOWEL SYNDROME; MONOSACCHARIDES; OLIGOSACCHARIDES; POLYMERS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84877743222     PISSN: 08845336     EISSN: 19412452     Source Type: Journal    
DOI: 10.1177/0884533613485790     Document Type: Review

References (78)

1. Hungin APS, Chang L, Locke GR, Dennis EH, Barghout V. Irritable bowel syndrome in the United States: prevalence, symptom patterns and impact. Aliment Pharmacol Ther. 2005 ; 21 (11). 1365-1375
2. Vandvik PO, Lydersen S, Farup PG. Prevalence, comorbidity and impact of irritable bowel syndrome in Norway. Scand J Gastroenterol. 2006 ; 41 (6). 650-656
3. Dapoigny M, Bellanger J, Bonaz B, et al. Irritable bowel syndrome in France: a common, debilitating and costly disorder. Eur J Gastroenterol Hepatol. 2004 ; 16 (10). 995-1001
4. Saito YA, Talley NJ, Melton L, Fett S, Zinsmeister AR, Locke GR. The effect of new diagnostic criteria for irritable bowel syndrome on community prevalence estimates. Neurogastroenterol Motil. 2003 ; 15 (6). 687-694
5. Ford AC, Talley NJ, Spiegel BM, et al. Effect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome: systematic review and meta-analysis [see comment]. BMJ. 2008 ; 337: a2313
6. Rees G, Davies J, Thompson R, et al. Randomised-controlled trial of a fibre supplement on the symptoms of irritable bowel syndrome. J R Soc Health. 2005 ; 125 (1). 30-34
7. Bijkerk CJ, Muris JW, Knottnerus JA, Hoes AW, de Wit NJ. Systematic review: the role of different types of fibre in the treatment of irritable bowel syndrome. Aliment Pharmacol Ther. 2004 ; 19 (3). 245-251
8. Serra J, Salvioli B, Azpiroz F, Malagelada JR. Lipid-induced intestinal gas retention in irritable bowel syndrome. Gastroenterology. 2002 ; 123 (3). 700-706
9. Caldarella MP, Milano A, Laterza F, et al. Visceral sensitivity and symptoms in patients with constipation- or diarrhea-predominant irritable bowel syndrome (IBS): effect of a low-fat intraduodenal infusion. Am J Gastroenterol. 2005 ; 100 (2). 383-389
10. Rao SS, Welcher K, Zimmerman B, Stumbo P. Is coffee a colonic stimulant?. Eur J Gastroenterol Hepatol. 1998 ; 10 (2). 113-118
11. Bujanda L. The effects of alcohol consumption upon the gastrointestinal tract. Am J Gastroenterol. 2000 ; 95 (12). 3374-3382
12. Zar S, Benson MJ, Kumar D. Food-specific serum IgG4 and IgE titers to common food antigens in irritable bowel syndrome. Am J Gastroenterol. 2005 ; 100 (7). 1550-1557
13. Aydinlar EI, Dikmen PY, Tiftikci A, et al. IgG-based elimination diet in migraine plus irritable bowel syndrome. Headache. 2013 ; 53 (3). 514-525
14. Ligaarden SC, Lydersen S, Farup PG. IgG and IgG4 antibodies in subjects with irritable bowel syndrome: a case control study in the general population. BMC Gastroenterol. 2012 ; 12: 166
15. Yang CM, Li YQ. The therapeutic effects of eliminating allergic foods according to food-specific IgG antibodies in irritable bowel syndrome [in Chinese]. Zhonghua Nei Ke Za Zhi. 2007 ; 46 (8). 641-643
16. Shanahan F, Whorwell PJ. IgG-mediated food intolerance in irritable bowel syndrome: a real phenomenon or an epiphenomenom?. Am J Gastroenterol. 2005 ; 100 (7). 1558-1559
17. Atkinson W, Sheldon TA, Shaath N, Whorwell PJ. Food elimination based on IgG antibodies in irritable bowel syndrome: a randomised controlled trial. Gut. 2004 ; 53 (10). 1459-1464
18. El Salhy M, Ostgaard H, Gundersen D, Hatlebakk JG, Hausken T. The role of diet in the pathogenesis and management of irritable bowel syndrome [review]. Int J Mol Med. 2012 ; 29 (5). 723-731
19. Swain A, Soutter V, Loblay R RPAH Elimination Diet Handbook. Sydney, Australia: Royal Prince Alfred Hospital ; 2009 :
20. Ravich WJ, Bayless TM, Thomas M. Fructose: incomplete intestinal absorption in humans. Gastroenterology. 1983 ; 84 (1). 26-29
21. Kneepkens CM, Vonk RJ, Fernandes J. Incomplete intestinal absorption of fructose. Arch Dis Child. 1984 ; 59 (8). 735-738
22. Stone-Dorshow T, Levitt MD. Gaseous response to ingestion of a poorly absorbed fructo-oligosaccharide sweetener. Am J Clin Nutr. 1987 ; 46 (1). 61-65
23. Rumessen JJ, Gudmand-Hoyer E. Functional bowel disease: malabsorption and abdominal distress after ingestion of fructose, sorbitol, and fructose-sorbitol mixtures. Gastroenterology. 1988 ; 95 (3). 694-700
24. Nelis GF, Vermeeren MA, Jansen W. Role of fructose-sorbitol malabsorption in the irritable bowel syndrome. Gastroenterology. 1990 ; 99 (4). 1016-1020
25. Born P, Vierling T, Barina W. Fructose malabsorption and the irritable bowel syndrome. Gastroenterology. 1991 ; 101 (5). 1454
26. Fernandez-Banares F, Esteve-Pardo M, Humbert P, de Leon R, Llovet JM, Gassull MA. Role of fructose-sorbitol malabsorption in the irritable bowel syndrome. Gastroenterology. 1991 ; 101 (5). 1453-1454
27. Ledochowski M, Widner B, Bair H, Probst T, Fuchs D. Fructose- and sorbitol-reduced diet improves mood and gastrointestinal disturbances in fructose malabsorbers. Scand J Gastroenterol. 2000 ; 35 (10). 1048-1052
28. Johlin FC, Panther M, Kraft N. Dietary fructose intolerance: diet modification can impact self-rated health and symptom control. Nutr Clin Care. 2004 ; 7 (3). 92-97
29. DiPalma JA, Narvaez RM. Prediction of lactose malabsorption in referral patients. Dig Dis Sci. 1988 ; 33 (3). 303-307
30. Rao DR, Bello H, Warren AP, Brown GE. Prevalence of lactose maldigestion: influence and interaction of age, race, and sex. Dig Dis Sci. 1994 ; 39 (7). 1519-1524
31. Villako K, Maaroos H. Clinical picture of hypolactasia and lactose intolerance. Scand J Gastroenterol Suppl. 1994 ; 202: 36-54
32. Gibson PR, Shepherd SJ. Personal view: food for thought - Western lifestyle and susceptibility to Crohn's disease. The FODMAP hypothesis. Aliment Pharmacol Ther. 2005 ; 21 (12). 1399-1409
33. Shepherd SJ, Gibson PR. Fructose malabsorption and symptoms of irritable bowel syndrome: guidelines for effective dietary management. J Am Diet Assoc. 2006 ; 106 (10). 1631-1639
34. Shepherd SJ, Parker SC, Muir JG, Gibson PR. Randomised, placebo-controlled evidence of dietary triggers for abdominal symptoms in patients with irritable bowel syndrome. Clin Gastroenterol Hepatol. 2008 ; 6 (7). 765-771
35. The Monash University Low FODMAP Diet. 4 th ed.Melbourne, Australia: Monash University; 2012. Melbourne, Australia: Monash University ; 2012 :
36. Ong DK, Mitchell SB, Barrett JS, et al. Manipulation of dietary short chain carbohydrates alters the pattern of gas production and genesis of symptoms in irritable bowel syndrome. J Gastroenterol Hepatol. 2010 ; 25: 1366-1373
37. Staudacher HM, Whelan K, Irving PM, Lomer MCE. Comparison of symptom response following advice for a diet low in fermentable carbohydrates (FODMAPs) versus standard dietary advice in patients with irritable bowel syndrome. J Hum Nutr Diet. 2011 ; 24 (5). 487-495
38. Biesiekierski JR, Rosella O, Rose R, et al. Quantification of fructans, galacto-oligosacharides and other short-chain carbohydrates in processed grains and cereals. J Hum Nutr Diet. 2011 ; 24 (2). 154-176
39. Muir J, Rose R, Rosella O, et al. Measurement of short chain carbohydrates (FODMAPs) in common Australian vegetables and fruit by high performance liquid chromatography. J Agric Food Chem. 2009 ; 57: 554-565
40. Muir JG, Shepherd SJ, Rosella O, Rose R, Barrett JS, Gibson PR. Fructan and free fructose content of common Australian vegetables and fruit. J Agric Food Chem. 2007 ; 55 (16). 6619-6627
41. Gearry RB, Irving PM, Nathan DM, Barrett JS, Shepherd SJ, Gibson PR. The effect of reduction of poorly absorbed, highly fermentable short-chain carbohydrates (FODMAPs) on the symptoms of patients with inflammatory bowel disease (IBD). JCC. 2009 ; 3 (1). 8-14
42. Bate JP, Irving PM, Barrett JS, Gibson PR. Benefits of breath hydrogen testing after lactulose administration in analysing carbohydrate malabsorption. Eur J Gastroenterol Hepatol. 2010 ; 22 (3). 318-326
43. Barrett JS, Irving PM, Shepherd SJ, Muir JG, Gibson PR. Prevalence of fructose and lactose malabsorption in patients with gastrointestinal disorders. Aliment Pharmacol Ther. 2009 ; 30: 165-174
44. Usai Satta P, Anania C, Astegiano M, Miceli E, Montalto M, Tursi A. H2-breath testing for carbohydrate malabsorption. Aliment Pharmacol Ther. 2009 ; 29: 14-18
45. Rao SS, Attaluri A, Anderson L, Stumbo P. Ability of the normal human small intestine to absorb fructose: evaluation by breath testing. Clin Gastroenterol Hepatol. 2007 ; 5 (8). 959-963
46. Simren M, Stotzer PO. Use and abuse of hydrogen breath tests. Gut. 2006 ; 55 (3). 297-303
47. Kellett GL, Brot-Laroche E. Apical GLUT2: a major pathway of intestinal sugar absorption. Diabetes. 2005 ; 54 (10). 3056-3062
48. Skoog SM, Bharucha AE, Zinsmeister AR. Comparison of breath testing with fructose and high fructose corn syrups in health and IBS. Neurogastroenterol Motil. 2008 ; 20 (5). 505-511
49. Truswell AS, Seach JM, Thorburn AW. Incomplete absorption of pure fructose in healthy subjects and the facilitating effect of glucose. Am J Clin Nutr. 1988 ; 48 (6). 1424-1430
50. Rorick MH, Scrimshaw NS. Comparative tolerance of elderly from differing ethnic backgrounds to lactose-containing and lactose-free dairy drinks: a double-blind study. J Gerontol. 1979 ; 34 (2). 191-196
51. Vesa TH, Korpela RA, Sahi T. Tolerance to small amounts of lactose in lactose maldigesters. Am J Clin Nutr. 1996 ; 64 (2). 197-201
52. Yao CK, Tan HL, can Langenberg DR, Barrett JS, Gibson PR, Muir JG. Abnormal intestinal handling of sorbitol and mannitol in patients with IBS: mechanistic insights and potential clinical implications. J Gastroenterol Hepatol. 2011 ; 26: 70
53. Rumessen JJ, Gudmand-Hoyer E. Fructans of chicory: intestinal transport and fermentation of different chain lengths and relation to fructose and sorbitol malabsorption. Am J Clin Nutr. 1998 ; 68 (2). 357-364
54. Macfarlane G, Steed H, Macfarlane S. Bacterial metabolism and health-related effects of galacto-oligosaccharides and other prebiotics. J Appl Microbiol. 2008 ; 104 (2). 305-344
55. Molis C, Flourie B, Ouarne F, et al. Digestion, excretion, and energy value of fructooligosaccharides in healthy humans. Am J Clin Nutr. 1996 ; 64 (3). 324-328
56. van Dokkum W, Wezendonk B, Srikumar T, van den Heuvel E. Effect of nondigestible oligosaccharides on large-bowel functions, blood lipid concentrations and glucose absorption in young healthy male subjects. J Clin Nutr. 1999 ; 53 (1). 1-7
57. Barrett JS, Gearry RB, Muir JG, et al. Dietary poorly absorbed, short-chain carbohydrates increase delivery of water and fermentable substrates to the proximal colon. Aliment Pharmacol Ther. 2010 ; 31 (8). 874-882
58. Marciani L, Cox EF, Hoad CL, et al. Postprandial changes in small bowel water content in healthy subjects and patients with irritable bowel syndrome. Gastroenterology. 2010 ; 138 (2). 469 77 e1-477
59. Pimentel M, Lin HC, Enayati P, et al. Methane, a gas produced by enteric bacteria, slows intestinal transit and augments small intestinal contractile activity. Am J Physiol Gastrointest Liver Physiol. 2006 ; 290 (6). G1089 - G1095
60. Chatterjee S, Park S, Low K, Kong Y, Pimentel M. The degree of breath methane production in IBS correlates with the severity of constipation. Am J Gastroenterol. 2007 ; 102 (4). 837-841
61. Pimentel M, Mayer AG, Park S, Chow EJ, Hasan A, Kong Y. Methane production during lactulose breath test is associated with gastrointestinal disease presentation. Dig Dis Sci. 2003 ; 48 (1). 86-92
62. Barrett JS, Shepherd SJ, Gibson PR. Strategies to manage gastrointestinal symptoms complicating enteral feeding. JPEN J Parenter Enteral Nutr. 2009 ; 33: 21-26
63. Halmos EP, Muir JG, Barrett JS, Deng M, Shepherd SJ, Gibson PR. Diarrhoea during enteral nutrition is predicted by the poorly absorbed short-chain carbohydrate (FODMAP) content of the formula. Aliment Pharmacol Ther. 2011 ; 32 (7). 925-933
64. Iacovou M, Ralston R, Muir J, Walker K, Truby H. Dietary management of infantile colic: a systematic review. Matern Child Health J. 2012 ; 16 (6). 1319-1331
65. Ritchie J. Pain from distension of the pelvic colon by inflating a balloon in the irritable colon syndrome. Gut. 1973 ; 14 (2). 125-132
66. Lembo T, Naliboff B, Munakata J, et al. Symptoms and visceral perception in patients with pain-predominant irritable bowel syndrome. Am J Gastroenterol. 1999 ; 94 (5). 1320-1326
67. Simren M, Abrahamsson H, Bjornsson ES. An exaggerated sensory component of the gastrocolonic response in patients with irritable bowel syndrome. Gut. 2001 ; 48 (1). 20-27
68. Dong WZ, Zou DW, Li ZS, et al. Study of visceral hypersensitivity in irritable bowel syndrome. Chin J Dig Dis. 2004 ; 5 (3). 103-109
69. Stacher G, Christensen J. Visceral hypersensitivity in irritable bowel syndrome: a summary review. Dig Dis Sci. 2006 ; 51 (3). 440-445
70. Nobaek S, Johansson ML, Molin G, Ahrne S, Jeppsson B. Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome. Am J Gastroenterol. 2000 ; 95 (5). 1231-1238
71. Fanigliulo L, Comparato G, Aragona G, et al. Role of gut microflora and probiotic effects in the irritable bowel syndrome. Acta Biomed. 2006 ; 77 (2). 85-89
72. Kassinen A, Krogius-Kurikka L, Makivuokko H, et al. The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects. Gastroenterology. 2007 ; 133 (1). 24-33
73. Parkes GC, Brostoff J, Whelan K, Sanderson JD. Gastrointestinal microbiota in irritable bowel syndrome: their role in its pathogenesis and treatment. Am J Gastroenterol. 2008 ; 103 (6). 1557-1567
74. Collins SM, Denou E, Verdu EF, Bercik P. The putative role of the intestinal microbiota in the irritable bowel syndrome. Dig Liver Dis. 2009 ; 41 (12). 850-853
75. Hamer HM, Jonkers D, Venema K, Vanhoutvin S, Troost FJ, Brummer RJ. Review article: the role of butyrate on colonic function. Aliment Pharmacol Ther. 2008 ; 27 (2). 104-119
76. Lewis S, Burmeister S, Brazier J. Effect of the prebiotic oligofructose on relapse of Clostridium difficile-associated diarrhea: a randomized, controlled study. Clin Gastroenterol Hepatol. 2005 ; 3 (5). 442-448
77. Staudacher HM, Lomer MCE, Anderson JL, et al. Fermentable carbohydrate restriction reduces luminal bifidobacteria and gastrointestinal symptoms in patients with irritable bowel syndrome. J Nutr. 2012 ; 142 (8). 1510-1518
78. Walker AW, Ince J, Duncan SH, et al. Dominant and diet-responsive groups of bacteria within the human colonic microbiota. ISME J. 2011 ; 5 (2). 220-230